Plasmafabriek Sanquin

Cinryze C1-inhibitor

C1-esterase inhibitor concentrate

Cinryze

As of December 2018, Sanquin has transferred the marketing and distribution rights of Cinryze for the Dutch, Belgian, Finnish and Turkish markets to Takeda.

Contact information

  • Contact information

    For further details, please contact:
    The Netherlands: Medical Lead: Egbert de Groot, tel. +31 (0) 6 52 57 91 65
    Finland: Kaisa Elomaa, Medical Affairs Lead – kaisa.elomaa@shire.com
    Mobile: +358 40 730 4289
    Belgium: Ann Ruttens – +32 (0) 475 32 53 91 – aruttens-c@shire.com